Haemonetics
HAE
#2913
Rank
โ‚น522.88 B
Marketcap
โ‚น11,482
Share price
1.60%
Change (1 day)
74.28%
Change (1 year)

EPS for Haemonetics (HAE)

EPS in 2026 (TTM): โ‚น212.57

According to Haemonetics's latest financial reports the company's current EPS (TTM) is โ‚น212.54. In 2025 the company made an earnings per share (EPS) of โ‚น341.94 an increase over its 2024 EPS that were of โ‚น239.66.

EPS history for Haemonetics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น212.57-37.83%
2025โ‚น341.9442.68%
2024โ‚น239.662.43%
2023โ‚น233.9733.73%
2022โ‚น174.97332.49%
2021โ‚น40.46
2018โ‚น83.62-363.15%
2017-โ‚น31.78-207.1%
2016โ‚น29.67-132.28%
2015-โ‚น91.91-269%
2014โ‚น54.39-20%
2013โ‚น67.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น624.30 193.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚น381.32 79.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
โ‚น1,775 735.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น131.78-162.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚น336.46 58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
โ‚น883.20 315.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น719.62 238.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
-โ‚น2.80-101.32%๐Ÿ‡บ๐Ÿ‡ธ USA